BMES-4154: Commercialization of BME Res
Description: Commercialization process applied to translational research. Regulatory aspects of biomedical engineering products and technologies (e.g. devices, diagnostics, drugs, biologics). Intellectual property, technology transfer processes, clinical trial design, commercialization of university research, modeling of development costs (e.g. cash flow and revenue projections). Small business startup approaches.
Pathways: N/A
Course Hours: 3 credits
Corequisites: N/A
Crosslist: N/A
Repeatability: N/A
Sections Taught: 4
Average GPA: 3.74 (rounds to A-)
Strict A Rate (No A-) : 56.49%
Average Withdrawal Rate: 1.47%
| Alexandra R Hyler | 2024 | 75.6% | 20.6% | 1.9% | 0.0% | 0.0% | 2.0% | 3.69 | 3 |
| Dyke Mark Van | 2019 | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 3.88 | 1 |